İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2025

The effect of spasticity severity on peripheral muscle oxygenation in hemiparetic stroke patients: a cross-sectional study

Topics in Stroke Rehabilitation

YÖKSİS OpenAlex SJR Q1 JCR Q2 Atıf 1 Yüzdelik 70.9% FWCI 0.7
Yıl
2025
ISSN
1074-9357
Tür
article

Veri kaynağı ayrımı

  • YÖKSİS YÖKSİS makale kaydı
  • OpenAlex OpenAlex zenginleştirmesi (özet, atıf, konular)

Özet

İngilizce (OpenAlex)

BACKGROUND: Spasticity-induced muscle changes affect structure and metabolism. Little is known about the effect of stroke-related muscle changes on peripheral muscle oxygenation. OBJECTIVE: To investigate the effect of spasticity severity on peripheral muscle oxygenation in patients with hemiparetic stroke. METHODS: This cross-sectional study was conducted with 20 hemiparetic stroke patients and 10 healthy individuals. The hemiparetic stroke patients were divided into the high-level spasticity group (HLS, MAS ≥ 2) and the low-level spasticity group (LLS, MAS < 2). Healthy individuals were included in the control group (CG). Gastrocnemius muscle oxygenation was measured with near-infrared spectroscopy at rest, during activity (6-minute walk test and stair climbing test) and after activity. Ankle plantar flexor spasticity was evaluated with the Modified Ashworth Scale (MAS). Secondary outcome measures were motor recovery, disability level, and calf adipose tissue thickness. RESULTS: = .011). Baseline and final muscle oxygen saturation were lower in HLS, differences were not significant. In HLS, muscle oxygen saturation during 6-minute walk test increased unexpectedly, while it decreased during recovery. CONCLUSIONS: Spasticity severity affected peripheral muscle oxygenation. In patients with high-level spasticity, resting average muscle oxygenation and changes in muscle oxygenation during recovery were lower, and different patterns were observed during 6MWT, suggesting impaired oxygen utilization and delivery, possibly related to spasticity severity. TRIAL REGISTRATION: Clinical trial registry: NCT06362954.

Konular

  • Botulinum Toxin and Related Neurological Disorders
  • Stroke Rehabilitation and Recovery
  • Cerebral Palsy and Movement Disorders

Birincil konu Botulinum Toxin and Related Neurological Disorders

Yazarlar

  1. SELCAN SUİÇMEZ ANKARA MEDİPOL ÜNİVERSİTESİ
  2. GÖKHAN YAZICI
  3. TAYLAN ALTIPARMAK
  4. ÇAĞLA ÇAĞATAY
  5. HALE ZEYNEP BATUR ÇAĞLAYAN
  6. BİJEN NAZLIEL